id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-N-1149-0108,FDA,FDA-2016-N-1149,FDA Summary of Premarket Review and Related Authorities for Medical Products _Jan 2025,Other,Summary (SUM),2025-01-06T05:00:00Z,2025,1,2025-01-06T05:00:00Z,,2025-01-06T13:37:41Z,,0,0,090000648689e39a
FDA-2016-N-1149-0107,FDA,FDA-2016-N-1149,Addendum to Jan 2017 FDA Memo--Additional and Updated Considerations Related to Manufacturer Communications Re Unapproved Uses of Approved or Cleared Medical Products_Jan 2025,Other,Additional Information,2025-01-06T05:00:00Z,2025,1,2025-01-06T05:00:00Z,,2025-01-06T13:37:28Z,,0,0,090000648689e398